[go: up one dir, main page]

ZM4579A1 - Triazine derivatives - Google Patents

Triazine derivatives

Info

Publication number
ZM4579A1
ZM4579A1 ZM45/79A ZM4579A ZM4579A1 ZM 4579 A1 ZM4579 A1 ZM 4579A1 ZM 45/79 A ZM45/79 A ZM 45/79A ZM 4579 A ZM4579 A ZM 4579A ZM 4579 A1 ZM4579 A1 ZM 4579A1
Authority
ZM
Zambia
Prior art keywords
alkyl
radical
phenyl
monocyclic
cycloalkyl
Prior art date
Application number
ZM45/79A
Other languages
English (en)
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of ZM4579A1 publication Critical patent/ZM4579A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/38Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40Nitrogen atoms
    • C07D251/42One nitrogen atom
    • C07D251/46One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
ZM45/79A 1978-05-26 1979-05-23 Triazine derivatives ZM4579A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2293878 1978-05-26

Publications (1)

Publication Number Publication Date
ZM4579A1 true ZM4579A1 (en) 1981-05-21

Family

ID=10187501

Family Applications (1)

Application Number Title Priority Date Filing Date
ZM45/79A ZM4579A1 (en) 1978-05-26 1979-05-23 Triazine derivatives

Country Status (24)

Country Link
US (1) US4254122A (fi)
EP (1) EP0005911B1 (fi)
JP (1) JPS54154779A (fi)
AT (1) ATE698T1 (fi)
AU (1) AU529948B2 (fi)
CA (1) CA1108138A (fi)
CS (1) CS213377B2 (fi)
DD (1) DD143906A5 (fi)
DE (1) DE2962124D1 (fi)
DK (1) DK213179A (fi)
ES (1) ES480932A1 (fi)
FI (1) FI66180C (fi)
GR (1) GR68185B (fi)
HU (1) HU180252B (fi)
IE (1) IE49170B1 (fi)
IL (1) IL57324A (fi)
MW (1) MW1379A1 (fi)
NO (1) NO791722L (fi)
NZ (1) NZ190402A (fi)
PH (1) PH14793A (fi)
PT (1) PT69650A (fi)
ZA (1) ZA792247B (fi)
ZM (1) ZM4579A1 (fi)
ZW (1) ZW9179A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
AU7080298A (en) * 1997-04-25 1998-11-24 Takeda Chemical Industries Ltd. Triazine derivatives, their production and agrochemical composition
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
EP1494715A1 (en) * 2002-04-17 2005-01-12 Medical Research Council Fp receptor antagonists or pgf2 aplha antagonists for treating menorrhagia
EP1660072A2 (en) * 2003-07-29 2006-05-31 Universitätsklinikum Münster Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer
US7199156B2 (en) * 2003-10-10 2007-04-03 Milos Chvapil Composition and method to treat solid tumors
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
MX2008014828A (es) * 2006-05-22 2009-02-06 Combinatorx Inc Metodos y composiciones para el tratamiento de enfermedades o condiciones asociadas con niveles incrementados de proteina c-reactiva, interleucina-6 o interferon-gamma.
US20090075955A1 (en) * 2007-09-19 2009-03-19 Combinatorx, Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
KR20100121601A (ko) * 2007-12-17 2010-11-18 콤비네이토릭스, 인코포레이티드 면역염증성 질환의 치료를 위한 치료요법
CA2752269C (en) 2009-02-13 2016-08-30 Hiroyuki Kai Novel triazine derivative and pharmaceutical composition comprising the same
ES2572481T3 (es) 2010-08-10 2016-05-31 Shionogi & Co Derivado de triacina y composición farmacéutica que tiene una actividad analgésica que contiene la misma
JP6075621B2 (ja) 2010-08-10 2017-02-08 塩野義製薬株式会社 新規複素環誘導体およびそれらを含有する医薬組成物
US9550763B2 (en) 2012-02-09 2017-01-24 Shionogi & Co., Ltd. Heterocyclic ring and carbocyclic derivative
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物
WO2022162689A1 (en) * 2021-01-26 2022-08-04 Council Of Scientific And Industrial Research Triazine-based self-assembling system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983116A (en) * 1973-04-05 1976-09-28 E. I. Du Pont De Nemours And Company Herbicidal triazines
US4035365A (en) * 1973-11-01 1977-07-12 Imperial Chemical Industries Limited Triazinediones
GB1543037A (en) * 1975-02-05 1979-03-28 Ici Ltd Selective herbicidal triazine-diones
US4082536A (en) * 1973-11-01 1978-04-04 Imperial Chemical Industries Limited Heterocyclic compounds and their use as pesticides
GB1464248A (en) 1973-11-01 1977-02-09 Ici Ltd Substituted triazinediones their preparation and use as herbicides
GB1504304A (en) * 1974-02-15 1978-03-15 Ici Ltd Process of combating fungal and bacterial infections of plants with triazine dione derivatives
GB1599518A (en) * 1977-02-21 1981-10-07 Ici Ltd 1,3,5-triazine-2,6-diones and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
ATE698T1 (de) 1982-03-15
DE2962124D1 (en) 1982-03-25
FI66180B (fi) 1984-05-31
PT69650A (en) 1979-06-01
NO791722L (no) 1979-11-27
DK213179A (da) 1979-11-27
AU529948B2 (en) 1983-06-30
HU180252B (en) 1983-02-28
MW1379A1 (en) 1981-04-08
IE790889L (en) 1979-11-26
US4254122A (en) 1981-03-03
PH14793A (en) 1981-12-09
ES480932A1 (es) 1980-02-01
CA1108138A (en) 1981-09-01
FI66180C (fi) 1984-09-10
NZ190402A (en) 1982-05-31
CS213377B2 (en) 1982-04-09
IE49170B1 (en) 1985-08-21
FI791670A (fi) 1979-11-27
DD143906A5 (de) 1980-09-17
EP0005911A1 (en) 1979-12-12
ZA792247B (en) 1980-05-28
JPS54154779A (en) 1979-12-06
IL57324A0 (en) 1979-09-30
AU4694979A (en) 1979-11-29
EP0005911B1 (en) 1982-02-17
ZW9179A1 (en) 1981-01-21
GR68185B (fi) 1981-11-09
IL57324A (en) 1983-10-31

Similar Documents

Publication Publication Date Title
ZW9179A1 (en) Triazine derivatives
NO163956C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive (4-piperidinylmetyl- og -hetero)puriner.
AU3945589A (en) Substituted 4-piperidinyl-indol-5-yl-alkyl-sulphonamide derivatives
DK491489A (da) Imidazolinderivater samt fremgangsmaade til fremstilling deraf
NO171915C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 1-azabicyklo(4.2.0)okt-2-en-derivater
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8401077A1 (es) Procedimiento para la obtencion de esteres del acido 7 2(2-amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido)-3-cefem-4-carboxilico.
IL78954A (en) Hydantoin spirocondensed with benzopyran and quinoline derivatives and pharmaceutical compositions containing them
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
DK168284A (da) Troponderivater
GR79114B (fi)
DK22983D0 (da) Fremgangsmade til fremstilling af penicillinderivater
EP0138223A3 (en) Thiazine derivatives, processes for preparation thereof and pharmaceutical conmposition comprising the same
MY103509A (en) Indole derivatives.